Product Reviews
Categories
- Alternative Medicine
- Cancer
- Acute Promyelocytic Leukemia
- Anal Cancer
- Bladder Cancer
- Breast cancer
- Colorectal cancer
- Endometrial Cancer
- Esophageal Cancer
- Gallbladder cancer
- Gastric Cancer
- Glioblastma
- Head and Neck Cancer
- Liver Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Nasopharyngeal Cancer
- Non-Hodgkin's Disease
- Ovarian Cancer
- Pancreatic Cancer
- Prostate cancer
- Renal Cancer
- Thyroid Cancer
- Cardiovascular disease
- Central Nervous System
- Constipation
- Diabetes
- Fatty Liver
- Irritable Bowel Syndrome
- Longevity
- Motherhood
- Obesity
- Others
- Psoriasis
- Respiratory Disease
- Rheumatoid Arthritis
Archives
Author Archives: wngai
Chocolate Consumption Lower Blood Pressure and Risk of Cardiovascular Disease
We previously have reported 2 studies that indicated chocolate could lower blood pressures and reduce risk of cardiovascular disease. Now, there is another study that supports the previous findings. The latest news came from a German study that evaluated the … Continue reading
Posted in Alternative Medicine, Cardiovascular disease, Heart attack, Hypertension, Stroke
Tagged blood pressure, Cardiovascular disease, Chocolate, Myocardial infarction, Stroke
Comments Off on Chocolate Consumption Lower Blood Pressure and Risk of Cardiovascular Disease
FDA Panel Supports the Use of Vandetanib in Medullary Thyroid Cancer
An FDA advisory committee reported that they supported the use of AstraZeneca’s vandetanib for the treatment of patients with medullary thyroid cancer (MTC). However, they also indicated the drug should be reserved for patients who are experiencing symptoms of their … Continue reading
Posted in Cancer, Thyroid Cancer
Tagged disease progression, Medullary Thyroid Cancer, vandetanib
Comments Off on FDA Panel Supports the Use of Vandetanib in Medullary Thyroid Cancer
Pertuzumab Plus Herceptin Shows Promise in Early Breast Cancer
Just after four cycles of neoadjuvant use, the combination of Roche’s pertuzumab, Herceptin (trastuzumab) and chemotherapy improved the rate of complete tumor disappearance by more than half compared to conventional therapy in patients with HER2-positive breast cancer. The results came … Continue reading
Posted in Breast cancer, Cancer
Tagged Breast cancer, HER2-positive, Herceptin, neoadjuvant, NEOSPHERE, Pertuzumab, Trastuzumab, tumor disappearance
Comments Off on Pertuzumab Plus Herceptin Shows Promise in Early Breast Cancer
FDA Approves the First Drug for Tuberous Sclerosis Tumors
Good news for patients with subependymal giant cell astrocytoma (SEGA). The US Food and Drug Administration (FDA) has granted the approval for everolimus (Afinitor, Novartis) as the first medication for children and adults with SEGA who require therapeutic intervention but … Continue reading
Posted in Cancer
Tagged Afinitor, Everolimus, subependymal giant cell astrocytoma, Tuberous Sclerosis Tumors, tumor, tumor shrinkage
Comments Off on FDA Approves the First Drug for Tuberous Sclerosis Tumors
Diastolic BP Lower than 70 mm Hg Increases CV Risk in Diabetic Patients
If you are a type 2 diabetic, you might like to maintain your blood pressure below 140/70 mm Hg but keeping your diastolic blood pressure above 70mm Hg. This can reduce your chance of having a heart attack, according to … Continue reading
Posted in Arrhythmia, Cardiovascular disease, Diabetes, Heart attack, Heart failure, Hypertension, Stroke
Tagged blood pressure, cardiovascular risk, Diabetes, diastolic blood pressure, Hypertension, systolic blood pressure
Comments Off on Diastolic BP Lower than 70 mm Hg Increases CV Risk in Diabetic Patients
Breast and Endometrial Cancer – Causes, Symptoms, Diagnosis, Prognosis and Hormonal Treatment
Breast Cancer Breast cancer is the most commonly diagnosed cancer in women and the second leading cause of cancer death in the United States. It is estimated that the lifetime risk of developing breast cancer is one in eight, with … Continue reading
Posted in Breast cancer, Cancer, Endometrial Cancer
Tagged anastrozole, Arimidex, Aromasin, aromatase inhibitors, AstraZeneca, Breast cancer, Causes, Depo-Provera, Diagnosis, Endometrial cancer, estrogen antagonist, estrogen receptor antagonist, exemestane, Fareston, Faslodex, Femara, fulvestrant, Gonadotropin-releasing hormone, goserelin, Her2, Hormonal treatment, letrozole, leuprorelin acetate, mammography, medroxyprogesterone, Megace, megestrol, Nolvadex, progestins, Prognosis, Selective Estrogen Receptors Modulator, SERMS, Symptoms, tamoxifen, toremifene, Viadur, Zoladex
1 Comment
New Drug to Prevent Future Strokes
As we all knew, patients who have a stroke or a transient ischemic attack have more than double the risk of having another attack. Now a subanalysis of RE-LY study which was published in The Lancet Neurology indicated that dabigatran … Continue reading
Posted in Cardiovascular disease, Stroke
Tagged dabigatran, Pradaxa, RE-LY, Stroke, system embolism, transient ischemic attack, Warfarin
Comments Off on New Drug to Prevent Future Strokes
